Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia

Journal of Clinical Immunology

Volumn 33, Issue 4, 2013, Pages 809-816

  Shan, Ning Ning ^a   Hu, Yu ^b   Liu, Xin ^a   Wang, Xin ^a   Yuan, Dai ^a   Li, Ying ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Aplastic anemia; cytokines; interleukin 18; RT PCR; T box; T cell immunoglobulin and mucin domain 3

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 4; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MESSENGER RNA; MUCIN 3; PROTEIN TIM 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RNA ANALYSIS;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CELL DIFFERENTIATION; CELL SEPARATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE COUNT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 84878020939     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9864-7     Document Type: Article

References (29)

1. Brodsky RA, Jones RJ. Aplastic anaemia. Lancet. 2004;365:1647-56.
2. Nakao S. Immune mechanism of aplastic anemia. Int J Hematol. 1997;66:127-34.
3. Zoumbos NC, Gascon P, Djeu JY, Young NS. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA. 1985;82:188-92.
4. Nistico A, Young NS. Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med. 1994;120:463-9.
5. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-γ and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol. 1995;165:538-46.
6. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996;9:532-62.
7. Monney L, Sabatos CA, Gaglia JL, Ryu H, Waldner T, Chernova S, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415:536-41.
8. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol. 2003;3:454-62.
9. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245-52.
10. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med. 2005;11:362-9.
11. Sa'nchez-Fueyo A, Tian J, Picarella D, Sánchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and allo-immune responses and promotes immunological tolerance. Nat Immunol. 2003;4:1093-101.
12. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63-70.
13. Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl. 1996;60:23-30.
14. Michael W, Graham W, Dempfle HL. Relative expression software tool(REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:1-10.
15. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318:1141-3.
16. Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol. 2006;18:665-9.
17. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of Tim3 in multiple sclerosis. J Exp Med. 2006;203:1413-8.
18. Wang Y, Meng J, Wang X, Liu S, Shu Q, Gao L, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol. 2008;67:63-70.
19. Idali F, Wahlström J, Dahlberg B, Khademi M, Olsson T, Eklund A, et al. Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res. 2009;10:42.
20. Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, et al. The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol. 2009;70:398-402.
21. Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene TIM-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett. 2004;95:91-5.
22. Keohane EM. Acquired aplastic anemia. Clin Lab Sci. 2004;17:165-71.
23. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100:1185-91.
24. Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006;107:3983-91.
25. Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK. Tim3-Galectin-9 pathway involves the suppression induced by CD4 CD25 regulatory T cells. Immunobiology. 2009;214:342-9.
26. Ju Y, Hou N, Zhang XN, Zhao D, Liu Y, Wang JJ, et al. Blockade of Tim-3 Pathway Ameliorates Interferon-γ Production. Cell Mol Immunol. 2009;6:35-43.
27. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991;88:346-50.
28. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655-69.
29. Anderson AC, Lord GM, Dardalhon V, Lee DH, Sabatos-Peyton CA, Glimcher LH, et al. T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur J Immunol. 2010;40:859-66.